Carobbi A et al. |
Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival. |
1991 |
Transplant. Proc. |
pmid:1703704
|
Murase N et al. |
FK 506 prevents spontaneous diabetes in the BB rat. |
1991 |
Transplant. Proc. |
pmid:1703705
|
Abou-Jaoude MM et al. |
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. |
2003 |
Transplant. Proc. |
pmid:14612103
|
Havrdova T et al. |
Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period. |
2011 |
Transplant. Proc. |
pmid:22099774
|
Guitard J et al. |
Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. |
2007 |
Transplant. Proc. |
pmid:17954189
|
Undre NA et al. |
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636527
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Gruessner RW et al. |
Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9532156
|
Rahamimov R et al. |
Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. |
2003 |
Transplant. Proc. |
pmid:12644082
|
Gavela MartÃnez E et al. |
Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715913
|
Hayashi S et al. |
Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). |
1997 |
Transplant. Proc. |
pmid:9193595
|
Sgrosso JL et al. |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. |
2002 |
Transplant. Proc. |
pmid:11959214
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. |
1993 |
Transplant. Proc. |
pmid:7679843
|
Ali Shah I et al. |
Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. |
1991 |
Transplant. Proc. |
pmid:1721276
|
Ohara K et al. |
Toxicologic evaluation of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689910
|
Wakizaka Y et al. |
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. |
1996 |
Transplant. Proc. |
pmid:8623372
|
Charpentier B |
An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids. |
2001 |
Transplant. Proc. |
pmid:11406262
|
Weir MR |
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation. |
2001 |
Transplant. Proc. |
pmid:11406264
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Tashiro H et al. |
Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats. |
2000 |
Transplant. Proc. |
pmid:11120201
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Bilodeau JF et al. |
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. |
2009 |
Transplant. Proc. |
pmid:19917367
|
Murata M et al. |
Unrelated donor bone marrow transplantation in Japanese patients is facilitated by the National Marrow Donor Program of the United States. |
1998 |
Transplant. Proc. |
pmid:9474987
|
Resch B et al. |
FK 506 and successful pregnancy in a patient after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9474990
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Katz HR et al. |
Mast cell biochemical and functional heterogeneity. |
1991 |
Transplant. Proc. |
pmid:1721308
|
Woo J et al. |
Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. |
1990 |
Transplant. Proc. |
pmid:1697112
|
Moscicka M et al. |
The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts. |
2003 |
Transplant. Proc. |
pmid:14529942
|
Kim SW et al. |
Decreased formation of nitric oxide in rats treated with FK506. |
2003 |
Transplant. Proc. |
pmid:12591357
|
Kim HC et al. |
Primary immunosuppression with tacrolimus in renal transplantation: a single center experience. |
2003 |
Transplant. Proc. |
pmid:12591370
|
Masuda S et al. |
Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919446
|
Tada H et al. |
Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919447
|
Ogino S et al. |
Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15041357
|
Ohtsuka S et al. |
The effect of short-term FK 506 therapy on pancreas transplantation using the cuff technique in rats. |
1992 |
Transplant. Proc. |
pmid:1376532
|
Ko S et al. |
Significance of newly developed liposomal FK 506 in canine liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533406
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
McDiarmid SV et al. |
FK 506 rescue therapy in liver transplantation: outcome and complications. |
1991 |
Transplant. Proc. |
pmid:1721339
|
Rucay P et al. |
FK 506 rescue therapy for refractory acute rejection in five liver recipients. |
1991 |
Transplant. Proc. |
pmid:1721340
|
Hodge EE et al. |
Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results. |
2002 |
Transplant. Proc. |
pmid:12176477
|
Ahlmén J et al. |
Positive effects of tacrolimus in a case of CIDP. |
1998 |
Transplant. Proc. |
pmid:9865344
|
Cicero A and Lappin JA |
Pancreas transplantation: experience at University of Texas, Houston. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172339
|
Barten MJ et al. |
Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12270442
|
Forgacs B et al. |
Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919502
|
Gaber LW et al. |
Renal histology with varying FK506 blood levels. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122955
|
Cohen DS et al. |
Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy. |
1996 |
Transplant. Proc. |
pmid:8907923
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
De Paolis P et al. |
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. |
2011 |
Transplant. Proc. |
pmid:21620039
|
Kitamura M et al. |
Clinical experience of FK 506 for renal allograft transplantation. |
1994 |
Transplant. Proc. |
pmid:7520611
|
Renner FC et al. |
Tacrolimus intoxication resolved by gastrointestinal bleeding: case report. |
2007 |
Transplant. Proc. |
pmid:17362773
|
Fung JJ et al. |
Adverse effects associated with the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721372
|
Omar G et al. |
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. |
1991 |
Transplant. Proc. |
pmid:1703356
|
Sanada O et al. |
Establishment of chimerism in donors by intraportal injection of recipient-type bone marrow cells with concomitant administration of FK 506 before liver transplantation prolongs liver allograft survival in rats. |
1998 |
Transplant. Proc. |
pmid:9838689
|
Kandaswamy R et al. |
Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083254
|
Sho M et al. |
Simultaneous inoculation of donor lymphocyte subsets with transplantation in a rat cardiac allograft model. |
1998 |
Transplant. Proc. |
pmid:9838696
|
Kramer MR et al. |
Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506). |
1997 |
Transplant. Proc. |
pmid:9290780
|
Tashiro H et al. |
Correlation of high-level microchimerism with graft acceptance in rat liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123287
|
Wijnen RM et al. |
Thymus atrophy in the nonhuman primate by FK506: an immunohistochemical study. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123292
|
Ierardi E et al. |
Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. |
2001 |
Transplant. Proc. |
pmid:11377467
|
Guckelberger O et al. |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? |
1996 |
Transplant. Proc. |
pmid:8962230
|
Jørgensen KA et al. |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176551
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
Braun F et al. |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. |
1996 |
Transplant. Proc. |
pmid:8962231
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Uchida J et al. |
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. |
2012 |
Transplant. Proc. |
pmid:22310596
|
Chen YB et al. |
Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population. |
2011 |
Transplant. Proc. |
pmid:21693271
|
Aono T et al. |
Minimal threshold of FK 506 for enhancing liver regeneration in thymectomized rats. |
1995 |
Transplant. Proc. |
pmid:7536981
|
Kobayashi N et al. |
Abdominal organ cluster transplantation in pigs receiving FK 506. |
1992 |
Transplant. Proc. |
pmid:1379754
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal transplant rejection. |
1996 |
Transplant. Proc. |
pmid:8769174
|
Jacobs TW et al. |
The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels. |
1991 |
Transplant. Proc. |
pmid:1721403
|
Yoshimura R et al. |
A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450. |
1992 |
Transplant. Proc. |
pmid:1379755
|
Baruch Y et al. |
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. |
1996 |
Transplant. Proc. |
pmid:8769215
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Reutzel-Selke A et al. |
Donor pretreatment of grafts from marginal donors improves long-term graft outcome. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267150
|
Mabuchi M et al. |
Insulin-like growth factor-I enhances choleretic action of FK506 in rats. |
2003 |
Transplant. Proc. |
pmid:12826230
|
Morrissey PE et al. |
Factors contributing to acute rejection in renal transplantation: the role of noncompliance. |
2005 |
Transplant. Proc. |
pmid:15964334
|
Rayes N et al. |
Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy. |
1998 |
Transplant. Proc. |
pmid:9723303
|
McLaughlin GE et al. |
Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. |
2000 |
Transplant. Proc. |
pmid:10812158
|
Lo A et al. |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12742477
|
Polanco N et al. |
Everolimus-based immunosuppression therapy for BK virus nephropathy. |
|
Transplant. Proc. |
pmid:25645770
|
El-Sabrout R et al. |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176636
|
Joo DJ et al. |
Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. |
2010 |
Transplant. Proc. |
pmid:21168645
|
Staak A et al. |
Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels. |
2006 |
Transplant. Proc. |
pmid:17175311
|
Moray G et al. |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. |
2006 |
Transplant. Proc. |
pmid:17175334
|
Wada H et al. |
An attempt to induce tolerance to skin grafts in congenic mice with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721435
|
Nojima M et al. |
Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function. |
|
Transplant. Proc. |
pmid:28104155
|
Calne R et al. |
Observations about FK-506 in primates. |
1987 |
Transplant. Proc. |
pmid:2445078
|
Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Percy C et al. |
Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:29149962
|
Torregrosa JV et al. |
Combined liver-kidney transplantation: our experience. |
1999 |
Transplant. Proc. |
pmid:10500591
|
Fischer S et al. |
Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11134815
|
Kelley M et al. |
Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. |
2005 |
Transplant. Proc. |
pmid:16213338
|
Hashi S et al. |
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. |
2014 |
Transplant. Proc. |
pmid:24767342
|
Wojarski J et al. |
Immunosuppressive Treatment and Its Effect on the Occurrence of Pneumocystis jiroveci, Mycoplasma pneumoniae, Chlamydophila pnemoniae, and Legionella pneumophila Infections/Colonizations Among Lung Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:30177108
|
Jensik SC |
Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636494
|
Takahashi K et al. |
Tacrolimus therapy for ABO-incompatible kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636495
|
Kanatani T et al. |
Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient. |
2004 |
Transplant. Proc. |
pmid:15686745
|
Hariharan S et al. |
Conversion from cyclosporine to tacrolimus after pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539799
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|